BS Summary: This article contains 2 faulty reasoning types, including Politically Left Leaning Bias, with Framing Effect as the most egregious example at 16.4% saturation with 35 hits. Analysis detected 70 faulty-reasoning hits from 213 analyzed words, generating a BS Score of 31% and a BS Rank of 13% (11,993 of 13,766 articles). This article is better (less manipulative) than 87.10% of the article peer group.
About halfway through 2026 — and just a few months before the critical midterm elections — Democrats appear to be doubling down on healthcare as a campaign issue as costs rise and insurance coverage declines.
Meanwhile, Congress is taking aim at nonprofit hospitals.
Shefali Luthra of The 19th, Rachel Roubein of The Washington Post, and Victoria Knight of Bloomberg Government join KFF Health News’ Julie Rovner to discuss these stories and more.
Also this week, Rovner interviews KFF Health News’ Samantha Liss, who wrote the latest "Bill of the Month" story, about a woman who changed Medicare Advantage plans and found herself at a disadvantage.
Plus, for "extra credit" the panelists suggest health policy stories they read this week that they think you should read, too:
Julie Rovner: Axios’ "Chinese Fentanyl Makers Find New U.S.
Market in Peptides", by Tina Reed.
Shefali Luthra: Stat's "Online GLP-1 Prescriptions Are Often Fast, Easy — And Low on Clinical Oversight", by Katie Palmer.
Rachel Roubein: The New York Times’ "Efforts To Help Smokers Quit Stall Under Trump", by Chistina Jewett.
Victoria Knight: Stat's "Booze Schmooze: The Alcohol Industry, Frazzled by Headwinds, Wields Its Power Behind the Scenes", by Isabella Cueto and Lev Facher.
For more about this episode, visit kffhealthnews.org/what-the-health.
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.